Herpangina Treatment Market Report 2026

Herpangina Treatment Market Overview

• Herpangina Treatment market size has reached to $1.96 billion in 2025 • Expected to grow to $2.87 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Growing Prevalence Of Herpangina Treatment Fuels The Growth Of The Herpangina Treatment Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Herpangina Treatment Market?

Herpangina treatment refers to a treatment of viral illness that usually affects youngsters, creating painful sores or ulcers on the tonsils and back of the throat. The treatment is used for managing symptoms and supporting the body's natural healing process, as herpangina is a viral infection that typically resolves on its own without specific antiviral medications. The main types of herpangina treatment are topical anesthetics, ibuprofen or acetaminophen, and others. Topical anesthetics are a form of local anesthesia that is applied to the skin's surface or mucous membrane to temporarily numb the region. They are caused by viruses such as coxsackie virus a, coxsackie virus b, enterovirus 71, and echovirus, with various symptoms such as high fever, sore throat, blisters or ulcers in the throat and mouth, difficulty swallowing, loss of appetite, headache, neck pain, and swollen lymph glands. They are used by various end-users, such as hospitals, home care, specialty clinics, and others.

What Is The Herpangina Treatment Market Growth Forecast?

The herpangina treatment market size is expected to see strong growth in the next few years. It will grow to $2.87 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to expansion of telehealth solutions, innovations in pain management therapies, rising homecare adoption, development of child-friendly formulations, growth in over-the-counter (OTC) medication adoption. Major trends in the forecast period include rise of pediatric telemedicine services, development of symptomatic relief formulations, increased awareness of viral infection management, adoption of homecare monitoring devices, growth in otc pain relief products.

Global Herpangina Treatment Market Segmentation

1) By Treatment: Topical Anesthetics, Ibuprofen Or Acetaminophen, Other Treatments 2) By Virus: Coxsackie Virus A, Coxsackie Virus B, Enterovirus 71, Echovirus 3) By Symptoms: High Fever, Sore Throat, Blisters Or Ulcers In The Throat Mouth, Difficulty Swallowing, Loss Of Appetite, Neck Pain, Swollen Lymph Glands, and Headache 4) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users

What Are The Drivers Of The Herpangina Treatment Market?

The increase in the number of research and development activities is expected to propel the growth of the herpangina treatment market going forward. Herpangina is a viral illness that usually affects youngsters, creating painful sores or ulcers on the tonsils and back of the throat caused by coxsackievirus and enteroviruses. Herpangina therapy helps to reduce the severity of herpangina symptoms such as blisters, high fever, discomfort in the mouth or throat, drooling, and loss of appetite. For instance, in January 2024, according to the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a US-based branch of the U.S. Food and Drug Administration (FDA), the CDER approved 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, compared to 37 novel drug approvals in 2022. Therefore, the increase in the number of research and development activities is driving the growth of the herpangina treatment industry. The rising pediatric population is expected to fuel the growth of the herpangina treatment market going forward. The pediatric population refers to young human beings who are in the early stage of life, typically from birth to adolescence or until reaching the age of maturity. The treatment of herpangina in the pediatric population typically focuses on managing symptoms, providing supportive care, and ensuring adequate hydration. For instance, in December 2024, according to the Federal Interagency Forum on Child and Family Statistics, a US-based collection of 23 federal government agencies involved in research and activities related to children and families, with 72.5 million children in the United States in 2022, the pediatric population is expected to grow to 78.2 million by 2050, reflecting a long-term upward trend. Therefore, the rising pediatric population is driving the growth of the herpangina treatment industry going forward. An increase in healthcare expenditure is expected to propel the growth of the herpangina treatment market going forward. Health expenditure refers to all costs for providing health services, nutrition activities, family planning activities, and emergency aid designated for health. The increased healthcare spending can aid in treating herpangina by expanding the availability of trained healthcare experts and resources. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), the US-based federal agency, National Health Expenditure (NHE) grew 7.5% to $4.9 trillion in 2023, or $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP). Hospital expenditures grew 10.4% to $1,519.7 billion in 2023, faster than the 3.2% growth in 2022. Therefore, an increase in healthcare expenditure is driving the growth of the herpangina treatment industry.

Key Players In The Global Herpangina Treatment Market

Major companies operating in the herpangina treatment market are Cipla Inc., Dr. Reddys Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Zydus Cadila, Aurobindo Pharma Ltd., Lupin Limited, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Mucocort, Aurena Laboratories AB, CSL Limited, Bayer AG, Sanofi, Johnson & Johnson, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim International GmbH, Pfizer Inc, Eli Lilly and Company

Regional Insights

North America was the largest region in the global herpangina treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Herpangina Treatment Market?

The herpangina treatment market consists of revenues earned by entities by providing medical services such as symptomatic relief, hydration, soft diet, and oral hygiene. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Herpangina Treatment Market Report 2026?

The herpangina treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the herpangina treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.